Skip to main content
. Author manuscript; available in PMC: 2024 Jan 8.
Published in final edited form as: AIDS. 2022 Jul 15;36(12):1697–1705. doi: 10.1097/QAD.0000000000003315

Table 2.

Estimated change in the number of persons with active antiretroviral prescriptions for HIV treatment in the United States, March 15, 2020–March 27, 2021.

Average March 2020-March 2021 Relative change % (95% Cl) 2020 Q2 March 15-Jun 27, 2020 Relative change % (95% Cl) 2020 Q3 June 28-September 26, 2020 Relative change % (95% Cl) 2020 Q4 September 27-December 26, 2020 Relative change % (95% Cl) 2021 Q1 December 27, 2020-March 27, 2021 Relative change % (95% Cl) End of 2021 Q1 March 21–27 2021 Relative Change % (95% Cl)
Total −2.5 (−3.8, −1.1) 0.0 (−1.4, 1.5) −2.1 (−3.5, −0.7) −3.6 (−4.9, −2.3) −4.6 (−5.9, −3.2) −5.3 (−6.6, −3.9)
Sex
 Male −2.9 (−4.6, −1.2) −0.1 (−1.9, 1.7) −2.5 (−4.2, −0.8) −4.1 (−5.8, −2.5) −5.2 (−6.8, −3.5) −5.8 (−7.4, −4.1)
 Female −1.2 (−2.7, 0.2) 0.5 (−1.0, 2.0) −0.9 (−2.3, 0.5) −2.0 (−3.4, −0.5) −2.8 (−4.2, −1.4) −3.6 (−5.0, −2.2)
Age group (years)
 13–24 −1.9 (−4.5, 0.8) −1.7 (−4.4, 1.1) −0.9 (−3.5, 1.8) −1.1 (−3.6, 1.5) −3.7 (−6.2, −1.1) −4.2 (−6.7, −1.6)
 25–34 −9.0 (−11.2, −6.8) −4.1 (−6.4, −1.8) −8.0 (−10.1, −5.8) −10.7 (−12.8, −8.6) −13.4 (−15.4, −11.3) −14.7 (−16.7, −12.6)
 35–44 −3.8 (−6.0, −1.5) −0.3 (−2.7, 2.2) −3.2 (−5.5, −0.9) −5.2 (−7.4, −3.0) −6.8 (−9.0, −4.5) −7.9 (−10.0, −5.6)
 45–54 −2.0 (−4.3, 0.4) 0.6 (−1.8, 3.0) −1.6 (−3.9, 0.8) −3.1 (−5.4, −0.9) −4.0 (−6.3, −1.7) −4.7 (−6.9, −2.3)
 55–64 −1.9 (−4.2, 0.5) 0.3 (−2.1, 2.7) −1.7 (−4.0, 0.6) −3.0 (−5.3, −0.7) −3.5 (−5.8, −1.1) −4.0 (−6.3, −1.6)
 ≥65 −1.5 (−3.7, 0.7) 0.0 (−2.2, 2.3) −1.4 (−3.6, 0.8) −2.2 (−4.3, −0.1) −2.7 (−4.8, −0.5) −3.3 (−5.4, −1.1)
Race and ethnicitya
 White −1.2 (−3.3, 0.9) 0.9 (−1.3, 3.1) −1.0 (−3.1, 1.1) −2.3 (−4.3, −0.2) −2.5 (−4.6, −0.4) −2.6 (−4.6, −0.5)
 Black −1.2 (−3.4, 1.1) 1.2 (−1.1, 3.6) −0.7 (−2.9, 1.6) −2.3 (−4.5, −0.1) −3.3 (−5.4, −1.0) −3.9 (−6.1, −1.7)
 Hispanic −0.6 (−3.6, 2.5) 1.8 (−1.4, 5.0) −0.3 (−3.3, 2.8) −1.7 (−4.6, 1.3) −2.5 (−5.5, 0.5) −2.8 (−5.8, 0.2)
 Asian/other 9.7 (7.0, 12.5) 7.7 (5.0, 10.5) 8.8 (6.1, 11.6) 9.6 (6.9, 12.3) 13.3 (10.5, 16.2) 15.6 (12.6, 18.6)
 Unknown −3.6 (−5.6, −1.4) −0.8 (−2.9, 1.5) −3.1 (−5.2, −1.0) −4.7 (−6.7, −2.6) −6.0 (−8.1, −3.9) −7.0 (−9.0, −4.9)
Census region
 Northeast −4.2 (−6.1, −2.2) −1.4 (−3.4, 0.7) −4.2 (−6.1, −2.2) −5.3 (−7.2, −3.3) −6.2 (−8.2, −4.2) −6.8 (−8.7, −4.8)
 Midwest −3.3 (−5.3, −1.3) −1.3 (−3.4, 0.8) −3.2 (−5.2, −1.2) −3.8 (−5.8, −1.9) −5.0 (−7.0, −3.0) −6.3 (−8.3, −4.3)
 South −2.1 (−4.4, 0.3) 0.5 (−1.9, 3.0) −1.3 (−3.7, 1.1) −3.4 (−5.7, −1.1) −4.3 (−6.6, −2.0) −4.8 (−7.1, −2.5)
 West −1.2 (−3.2, 0.9) 1.5 (−0.6, 3.7) −0.9 (−3.0, 1.1) −2.2 (−4.2, −0.2) −3.4 (−5.4, −1.4) −4.1 (−6.1, −2.1)
Insuranceb
 Public 1.9 (−0.1, 3.9) 2.8 (0.7, 4.8) 1.9 (0.0, 3.9) 1.7 (−0.2, 3.7) 1.2 (−0.8, 3.2) 0.6 (−1.4, 2.6)
 Private −1.3 (−3.2, 0.7) 2.1 (0.1, 4.2) −0.7 (−2.6, 1.3) −2.9 (−4.8, −1.0) −4.3 (−6.2, −2.3) −5.3 (−7.2, −3.4)
 Cash −13.2 (−15.6, −10.7) −15.3 (−17.7, −12.8) −14.1 (−16.6, −11.7) −12.4 (−14.8, −10.0) −11.0 (−13.5, −8.4) −10.1 (−12.7, −7.5)
 Other/Assistance Programs −4.5 (−6.6, −2.4) 2.8 (0.5, 5.1) −3.4 (−5.5, −1.3) −7.8 (−9.8, −5.8) −10.1 (−12.0, −8.1) −10.9 (−12.8, −8.9)
 Unknown −15.1 (−16.7, −13.5) −12.2 (−13.8, −10.5) −14.3 (−15.9, −12.7) −16.2 (−17.8, −14.7) −17.7 (−19.3, −16.2) −18.0 (−19.5, −16.4)

CI −confidence interval.

a

Other race and ethnicity included American Indian or Alaska Native and Native Hawaiian or Other Pacific Islander. Over 67% of persons had missing race and ethnicity information so these estimates might be unstable.

b

Public insurance includes Medicare and Medicaid; other includes federal and state assistance programs, drug manufacturer medication assistance programs, and medication coupon programs.